SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 134 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,772,000 | -22.2% | 211,698 | -15.9% | 0.28% | -26.2% |
| Q3 2019 | $2,278,000 | -16.0% | 251,698 | 0.0% | 0.38% | -11.7% |
| Q2 2019 | $2,711,000 | +19.0% | 251,698 | +5.4% | 0.44% | +19.5% |
| Q1 2019 | $2,279,000 | +28.1% | 238,857 | +54.1% | 0.36% | +22.1% |
| Q4 2018 | $1,779,000 | -32.3% | 154,960 | 0.0% | 0.30% | -27.4% |
| Q3 2018 | $2,627,000 | +26.7% | 154,960 | +6.1% | 0.41% | +19.4% |
| Q2 2018 | $2,073,000 | +13.7% | 146,000 | +52.1% | 0.34% | +4.9% |
| Q1 2018 | $1,824,000 | – | 96,000 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,000,000 | $66,540,000 | 6.69% |
| FIC CAPITAL INC | 787,529 | $8,734,000 | 3.47% |
| RA Capital Management | 1,220,209 | $13,532,000 | 1.36% |
| PRINCETON CAPITAL MANAGEMENT INC | 114,120 | $1,266,000 | 0.67% |
| Perceptive Advisors | 800,000 | $8,872,000 | 0.53% |
| Cormorant Asset Management, LP | 361,000 | $4,003,000 | 0.53% |
| Highlander Capital Management, LLC | 43,500 | $482,000 | 0.43% |
| APEX CAPITAL, LLC | 439,900 | $4,878,000 | 0.42% |
| WASATCH ADVISORS LP | 3,091,386 | $34,283,000 | 0.37% |
| Baker Brothers Advisors | 3,230,932 | $35,831,000 | 0.31% |